Summary
Cytostatic factor (CSF) arrests vertebrate eggs in metaphase of meiosis II through several pathways that inhibit activation of the anaphase-promoting complex/cyclosome (APC/C) [1] [2] [3] . In Xenopus, the Mos-MEK1-MAPK-p90
Rsk cascade utilizes spindleassembly-checkpoint components to effect metaphase arrest. Another pathway involves cyclin E-Cdk2, and sustained cyclin E-Cdk2 activity in egg extracts causes metaphase arrest in the absence of Mos; this latter finding suggests that an independent pathway contributes to CSF arrest [4, 5] . Here, we demonstrate that metaphase arrest with cyclin E-Cdk2, but not with Mos, requires the spindle-checkpoint kinase monopolar spindles 1 (Mps1), a cyclin E-Cdk2 target that is also implicated in centrosome duplication [6, 7] . xMps1 is synthesized and activated during oocyte maturation and inactivated upon CSF release. In egg extracts, CSF release by calcium was inhibited by constitutively active cyclin E-Cdk2 and delayed by wild-type xMps1. Ablation of cyclin E by antisense oligonucleotides blocked accumulation of xMps1, suggesting that cyclin E-Cdk2 controls Mps1 levels. During meiosis II, activated cyclin E-Cdk2 significantly inhibited the APC/C even in the absence of the Mos-MAPK pathway, but this inhibition was not sufficient to suppress S phase between meiosis I and II. These results uniquely place xMps1 downstream of cyclin E-Cdk2 in mediating a pathway of APC/C inhibition and metaphase arrest.
Results and Discussion
Cytostatic factor (CSF) arrests vertebrate eggs at metaphase of the second meiotic division, and elevated free calcium at fertilization terminates arrest [1] . Classically assayed by cleavage arrest of embryonic blastomeres, CSF is defined as an activity that causes metaphase arrest rather than a single protein or factor (reviewed in [2, 3] ). CSF arrest can be maintained in extracts from unfertilized eggs, and CSF release into anaphase can be triggered by addition of calcium to the extracts [8, 9] . One pathway contributing to CSF arrest is initiated by Mos accumulation during oocyte maturation, and cycling extracts from activated eggs biochemically recapitulate CSF arrest when purified Mos kinase is added [10] . Depletion-reconstitution experiments show that establishment of CSF arrest by Mos requires the MAPK-Erk kinase 1 (MEK1)-mitogen-activated protein kinase (MAPK)-90 kDa ribosomal protein S6 kinase (p90 Rsk ) cascade and the budding uninhibited by benzimidazole (Bub) and mitotic-arrest-deficient (Mad) proteins involved in the spindle checkpoint [2, 10] .
Cycling egg extracts have identified cyclin E-Cdk2 as a potential CSF component. Cyclin E-Cdk2 is first synthesized and activated during meiosis II and, like Mos, can establish metaphase arrest in egg extracts [4, 5, 11] . Upon CSF release by calcium, cyclin E-Cdk2 is transiently inhibited in anaphase by Tyr-15 phosphorylation of Cdk2 [4, 11, 12] . Constitutively active cyclin E-Cdk2 (Cdk2AF for Thr-14Ala and Tyr-15Phe) blocks calciuminduced CSF release (anaphase), and in cycling egg extracts, it is sufficient to cause arrest in metaphase [4, 5] . Importantly, extract arrest occurs without activation of the Mos pathway [5] .
Another pathway of anaphase-promoting complex/ cyclosome (APC/C) inhibition involved in CSF arrest involves Emi2, a protein identified in a two-hybrid screen for Plx1 interactors. Emi2 can cause metaphase arrest in cycling egg extracts in which the Mos-MAPK pathway is absent, indicating that like cyclin E-Cdk2, it is capable of independent inhibition of the APC/C [5, 13, 14] . The mechanism of APC/C inhibition by Emi2 is not yet clear but may involve direct binding of Cdc20 [15] .
Metaphase arrest established by CSF and the spindleassembly checkpoint are biochemically similar but occur in different contexts and are regulated by different signals. Whereas the spindle checkpoint monitors attachment of microtubules to kinetochores or tension [16] , CSF arrest in egg extracts, monitored biochemically as APC/C inhibition and M phase kinase activity, can occur in the absence of centrosomes, kinetochores, and even DNA. Finally, unlike spindle-checkpoint arrest, CSF arrest is released by calcium, and CSF establishment and release are unaffected by microtubule depolymerization.
To study connections among cyclin E-Cdk2, APC/C inhibition, and metaphase arrest, we have focused on Mps1 because it has been reported to be a cyclin E-Cdk2 substrate for centrosome duplication [6] and is also required for the spindle-assembly checkpoint [7] . We asked whether xMps1 fits the criteria for a CSF component [1] . As shown in Figure 1A , xMps1 is absent in immature (stage VI) oocytes, is synthesized after progesterone treatment, and is present in mature, CSFarrested eggs. After CSF release by calcium, xMps1 electrophoretic mobility increases rapidly ( Figure 1A ). Protein phosphatase 1g (PP1g) downshifted wild-type xMps1 to the same electrophoretic mobility as kinasedead xMps1 ( Figure 1B) . In a kinase assay, wild-type xMps1 phosphorylated itself and myelin basic protein (MBP), whereas the kinase-dead enzyme showed no activity. Phosphatase treatment dramatically reduced both autophosphorylation and phosphorylation of MBP by wild-type xMps1 ( Figure 1B ). The apparent *Correspondence: jim.maller@uchsc.edu residual activity after phosphatase treatment may reflect autoactivation of the enzyme during the assay. Thus, xMps1 activity is regulated by phosphorylation, and the electrophoretically retarded form is the active kinase. This pattern of xMps1 expression, activation, and inactivation is fully consistent with criteria identifying a CSF component. xMps1 was immunodepleted from cycling egg extracts so that its role in establishment of CSF arrest could be determined. A control extract entered mitosis after 15 min with high cyclin B2 levels and condensed chromosomes for 30 min, after which nuclei were in interphase ( Figure 2A ; see also Figure S1A in the Supplemental Data available online). The second mitosis occurred at 90 min and lasted until 135 min, when cyclin B2 was degraded and interphase nuclei were again observed. The level of xMps1 did not change, but the electrophoretic mobility oscillated with the retarded (active) form coinciding with mitosis ( Figure 2B ). When added at time 0, either GST-Mos or cyclin E-GST-Cdk2AF caused the extract to stably arrest in M phase ( Figure 2A and Figure S1A ). Mos arrested the extract in the first mitosis, whereas cyclin E-Cdk2AF caused arrest in the second mitosis [5] . Both arrests were stable until the end of the experiment at 180 min. For determining whether cyclin E-Cdk2 directly inhibited the APC/C or instead blocked its activation by endogenous xCdc20, purified xCdc20 was added to a cycling extract arrested by cyclin E-Cdk2AF. As shown in Figure S1C , xCdc20 was able to overcome metaphase arrest by cyclin E-Cdk2AF, suggesting that there was blockade of APC/C activation rather than direct inhibition. Arrest at the second cycle by cyclin E-Cdk2 is reproducible and occurs with all the criteria of CSF arrest, including metaphase-arrested spindles with meiotic morphology [5] . If cyclin E-Cdk2 is in a complex that regulates M phase exit, the extract may need to traverse a cell cycle for a complex to be dissociated and reassembled with cyclin E-Cdk2AF. Importantly, a similar situation was reported previously for centrosome duplication in egg extracts, in which only the second and subsequent rounds of duplication were blocked by inhibition of cyclin E-Cdk2 [17] . Depletion of xMps1 ( Figure 2A and Figure S1B ) had no effect on CSF arrest with Mos, but it blocked arrest when cyclin E-Cdk2AF was added ( Figure 2A and Figure S1A ). Recombinant xMps1 was added to immunodepleted extracts when cyclin E-Cdk2AF was added. Wild-type but not kinase-dead xMps1 restored metaphase arrest to depleted extracts when cyclin E-Cdk2AF was added, as indicated by stabilized cyclin B2 and condensed chromosomes ( Figure S3 ). Both GST-WT and GST-KD-xMps1 were stable after addition ( Figure S2 ). These results indicate that the kinase activity of xMps1 is required for metaphase arrest by cyclin E-Cdk2 but not by Mos.
In mouse cells, the Mps1 protein is unstable and does not accumulate until cyclin E-Cdk2 is activated at the G1/S transition [6] . We found that the Cdk inhibitor p27
Xic1 inhibited cyclin E-Cdk2 activity in meiosis II but had no detectable effect on cyclin B-Cdc2 activity, which accounts for over 95% of total histone H1 activity ( Figure S4 ). p27
Xic1 -injected oocytes appeared to mature normally and underwent germinal vesicle breakdown (GVBD) at the same time as control oocytes and to the same extent. The level of xMps1 protein was reduced by at least 50 percent in p27
Xic1 -injected oocytes ( Figure S4B ), but they still arrested at meiosis II with high cyclin B-Cdc2 activity ( Figure S4E reflect the fact that xMps1 levels were only partially reduced. For complete ablation of cyclin E, oocytes were injected with morpholino antisense oligonucleotides against cyclin E prior to progesterone treatment. As shown in Figure 2C , no cyclin E was detectable at MII, and, importantly, no xMps1 was present at MII (Figure 2C) . However, CSF arrest still occurred in the absence of both cyclin E and xMps1, with active MPF indicated by the shifted form of cyclin B2 ( Figure 2C ) and by MII oocyte morphology (not shown). CSF arrest also occurred in oocytes in which only xMps1 was ablated by morpholino antisense oligonucleotides (not shown). These results imply a link between cyclin E and xMps1 stability as suggested previously by Fisk and Winey [6] , but we cannot at the present time exclude an effect of cyclin E-Cdk2 on the synthesis of xMps1. The establishment of CSF arrest in oocytes lacking cyclin E ( Figure 2C ) differs from previous results in which CSF arrest was blocked with nonmorpholino antisense oligonucleotides against Cdk2 [19] . The earlier result was obtained before Xenopus cyclin E was cloned and might have been a result of other Cdk2 functions, e.g., binding to RINGO [20] or nonspecific effects of the oligonucleotides or mRNA fragments. Morpholinos do not produce mRNA fragments, only inhibition of translation, with no evidence of nonspecific effects. Importantly, a similar situation has been reported for the role of Mos in oocyte maturation. Early antisense oligonucleotide experiments repeated in many laboratories ablated Mos and blocked GVBD in meiosis I; this led to the dogma, held for many years, that Mos accumulation was required for meiosis I [21, 22] . However, more recent experiments with UO126 or morpholino antisense oligonucleotides have shown that the Mos-MAPK pathway is not required for meiosis I [23, 24] , and the earlier results may have reflected nonspecific oligo effects on protein synthesis.
Even though their activities are not required to establish CSF arrest, both kinases may need to be inactivated for CSF release. To investigate this point further, we added calcium and either cyclin E-Cdk2AF or xMps1 to CSF extracts and monitored the level of cyclin B2 and histone H1 kinase activity ( Figures 3A and 3B) . Kinase-dead xMps1 had no effect on CSF release, but wild-type xMps1 significantly delayed CSF release by calcium ( Figure 3B ). The extent of the delay was correlated with the time required for dephosphorylation of added xMps1 after calcium addition ( Figure 3B) . Cyclin E-Cdk2AF completely blocked CSF release with calcium ( Figure 3A ) as previously reported [4] . Taken together, these findings tempt us to speculate that the inactivation of xMps1 is also required for CSF release; this is a possibility that can only be fully evaluated when a constitutively active form of xMps1 is available.
We asked whether cyclin-E-Cdk2-mediated APC/C inhibition in vivo is independent of other pathways of CSF arrest and whether such inhibition is sufficient to establish CSF arrest. Previous data have shown that treatment of oocytes with the MEK1 inhibitor UO126 affects the kinetics but not the extent of entry into meiosis [23] . Earlier experiments also showed that ablation of Mos after GVBD led to M phase exit and DNA replication [25] . Oocytes lacking MAPK-pathway activation due to UO126 treatment exhibit lower activation of histone H1 kinase activity than controls, are unable to sustain meiosis after GVBD (MI), and thus lead to cyclin B degradation and entry into S phase [23] . Because cyclin E, Cdk2 [11] , and Emi2 [14] are not synthesized until at least 2 hr after GVBD, UO126-treated oocytes provide a system for evaluating the action of cyclin E-Cdk2 in the absence of other known CSF pathways. Accordingly, oocytes were matured with progesterone in the presence of U0126 and injected with cyclin E-Cdk2AF within 10 min of GVBD. UO126 treatment inhibited MAPK activity and led to exit from M phase after GVBD as judged by cyclin B degradation and reduced histone H1 kinase activity ( [23] and Figures 4A and 4B) . Cyclin E-Cdk2AF stabilized cyclin B2 levels and histone H1 kinase activity relative to controls in both the absence and presence of UO126 ( Figure 4A ). As reported previously [5] , cyclin E-Cdk2AF exhibited APC/C inhibitory activity in control oocytes such that little or no cyclin B2 degradation or loss of histone H1 kinase activity occurred between MI and MII ( Figures 4A and 4B ). Significant stabilization of cyclin B2 and increased histone H1 kinase activity were also observed in the presence of UO126, indicating that cyclin E-Cdk2 can inhibit the APC/C independently of the MAPK pathway ( Figures 4A and 4B) . With UO126 treatment, the increased histone H1 kinase activity and cyclin B2 levels in the oocytes injected with cyclin E-Cdk2AF were, after anaphase I, at a level near those in control oocytes that remain in M phase. However, cyclin B2 levels and histone H1 kinase activity did not increase by 120 min after GVBD as expected for establishment of CSF arrest ( Figures 4A and 4B ). Despite the stabilizing effect of cyclin E-Cdk2AF on cyclin B2 levels ( Figure 4A , middle panel) and histone H1 kinase activity ( Figure 4B, right panel) , UO126-treated Figure 3 . Cyclin E-Cdk2AF Blocks, and Active xMps1 Delays, Release of CSF Arrest CSF extracts prepared from unfertilized eggs were released from metaphase arrest with calcium in the presence of either cyclin E-GST-Cdk2AF (A), or wild-type and kinase-dead GST-xMps1 (B). Samples taken at the indicated times were used to measure the kinetics of cyclin B2 degradation (left panels) and histone H1 kinase activity (right panels) during CSF release as indicated. In the absence of calcium (control), extracts remained arrested in M phase. Extracts were supplemented with 50 nM cyclin E-GST-Cdk2AF or GST alone (control) in (A) and 40 ng/ml of GST, wild-type (WT) GST-xMps1, or kinase-dead (KD) GST-xMps1 in (B). The lower panel of (B) shows immunoblotting of added kinase-dead (KD) and wild-type (WT) GST-Mps1 in the same extract samples after calcium addition.
oocytes exited meiosis after GVBD and were in interphase, synthesizing DNA, with accumulation of endogenous inactive Tyr15-phosphorylated Cdk complexes characteristic of S phase ( Figures 4A, right panel,  and 4C ). These oocytes also exhibited morphological changes associated with interphase (data not shown). Figure 4 clearly shows that although cyclin E-Cdk2AF inhibited the APC/C, this pathway is insufficient to suppress S phase and support the MI / II transition. An analogous result was reported previously for the Mos-MAPK pathway. In those experiments, microinjection of cycloheximide immediately after GVBD (which would prevent synthesis of Emi2 and cyclin E) led to exit from meiosis [22] . Although endogenous Mos was degraded during this exit, substantial MAPK-pathway activation by coinjection of purified recombinant Mos was insufficient to maintain M phase [22] . The inability of an activated MAPK pathway to maintain M phase in isolation supports a model in which multiple pathways of APC/C inhibition are necessary so that S phase between meiosis I and II can be suppressed. It is notable that cyclin E-Cdk2AF was insufficient for entry into meiosis II in vivo in the presence of UO126, even though the same level of exogenous kinase activity could prevent CSF release (anaphase) by calcium addition to extracts ( Figures 3A, 4A , and 4B). These results are consistent with the concept of hysteresis in models of cell-cycle transitions [26] .
Our results identify the xMps1 kinase as a necessary element in the pathway of APC/C inhibition for cyclin E-Cdk2, but not for Mos, during oocyte maturation. Mps1 is also a key player in the spindle checkpoint; it P]-dCTP (3000 Ci/ mmol; 10 mCi/ml) and either GST or cyclin E-GST-Cdk2AF. Oocytes were collected immediately after injection and 4 hr after GVBD. Some oocytes were transferred to medium containing 100 mg/ml cycloheximide (CHX) as a positive control for exit from meiosis and DNA synthesis [22, 23] .
is localized to kinetochores and promotes kinetochore recruitment of the Bub and Mad proteins, although Mps1-checkpoint functions that do not require kinetochore binding have also been reported [27] . These functions independent of DNA may be relevant for CSFdependent APC/C inhibition, which can be observed in egg extracts in the absence of DNA.
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